Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoichiro Hirata

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Drugs - Real World Outcomes|October 19, 2024
Clinical Significance of Prior Ramucirumab Use on the Effectiveness of Nivolumab as the Third-Line Regimen in Gastric Cancer: A Multicenter Retrospective StudyYuka Obayashi, Shoichiro Hirata, Yoshiyasu Kono, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 25, 2024
Clinical significance of gastrointestinal bleeding history in patients who undergo left atrial appendage closureTatsuya Kikuchi, Yoshiyasu Kono, Koji Nakagawa, et al.
Cancers|August 28, 2025
Prognostic Impact of Gastrointestinal Immune-Related Adverse Events Depends on Nutritional Status in Cancer Patients Treated with Immune Checkpoint InhibitorsShoichiro Hirata, Yoshiyasu Kono, Emi Tanaka, et al.
Journal of Gastroenterology and Hepatology|October 4, 2024
Rates and risk factors of bleeding after gastric endoscopic submucosal dissection with continuous warfarin or 1-day withdrawal of direct oral anticoagulantsShoichiro Hirata, Kenta Hamada, Masaya Iwamuro, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Drugs - Real World Outcomes|October 19, 2024
Clinical Significance of Prior Ramucirumab Use on the Effectiveness of Nivolumab as the Third-Line Regimen in Gastric Cancer: A Multicenter Retrospective StudyYuka Obayashi, Shoichiro Hirata, Yoshiyasu Kono, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 25, 2024
Clinical significance of gastrointestinal bleeding history in patients who undergo left atrial appendage closureTatsuya Kikuchi, Yoshiyasu Kono, Koji Nakagawa, et al.
Cancers|August 28, 2025
Prognostic Impact of Gastrointestinal Immune-Related Adverse Events Depends on Nutritional Status in Cancer Patients Treated with Immune Checkpoint InhibitorsShoichiro Hirata, Yoshiyasu Kono, Emi Tanaka, et al.
Journal of Gastroenterology and Hepatology|October 4, 2024
Rates and risk factors of bleeding after gastric endoscopic submucosal dissection with continuous warfarin or 1-day withdrawal of direct oral anticoagulantsShoichiro Hirata, Kenta Hamada, Masaya Iwamuro, et al.
Pageof 2